• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.01% Nasdaq Up0.26%

    pSivida Corp. (PSDV)

    3.90 Up 0.11(2.90%) Nov 25, 4:00PM EST
    ProfileGet Profile for:
    pSivida Corp.
    480 Pleasant Street
    Suite B300
    Watertown, MA 02472
    United States - Map
    Phone: 617-926-5000
    Fax: 617-926-5050
    Website: http://www.psivida.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:26

    Business Summary 

    pSivida Corp. develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company also develops Medidur, an injectable, sustained-release micro-insert designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye, which is in pivotal Phase III clinical trials. Its pre-clinical development program focuses on developing products using its core platform technologies, Durasert and Tethadur, to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. The company has strategic collaborations with Alimera Sciences, Inc.; Pfizer, Inc.; Bausch & Lomb Incorporated; and Enigma Therapeutics Limited. pSivida Corp. was founded in 1987 and is headquartered in Watertown, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on pSivida Corp.

    Key Executives 
    Dr. Paul Ashton B.Sc., Ph.D., 54
    Chief Exec. Officer, Pres and Exec. Director
    Mr. Leonard S. Ross , 65
    Principal Financial & Accounting Officer and VP of Fin.
    Ms. Lori H. Freedman Esq., B.A., J.D., 48
    VP of Corp. Affairs, Gen. Counsel and Company Sec.
    Mr. Marty Nazzaro ,
    VP of Operations
    Dr. Anna Kluczewska B.D.Sc.,
    Chief Exec. Officer of AION Diagnostics Limited, Pres of AION Diagnostics Limited and Director of AION Diagnostics Limited
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders